新兴光学成像剂报告建议:推动临床审批
该建议针对术中荧光成像的标准化报告方法提出最低要求,强调临床试验应呈现术中成像、标本定位与病理对照、靶点验证三项关键内容,并规范定性分析与定量分析(含术中数据、新鲜组织标本定位、靶点验证)的报告要素,以提升结果可比性并加速FDA审批。
要点
- 荧光引导手术临床试验应报告术中成像、标本定位与病理对照、靶点验证三项关键内容。
- 定性分析应包括明场图像、黑白荧光图像、伪彩荧光叠加图像和/或热图。
- 定量分析应包括术中数据(图像或视频、原始数值及比值)、新鲜组织标本定位及靶点验证。
核心结论
- 标准化荧光成像报告方法可提高可重复性并减少机构间与机构内差异,使试验结果具有可比性并可在未来研究中汇总,以加速FDA审批。
研究设计与样本
- 该文为Theranostics发表的建议性文件,提出基于定性与(半)定量数据采集的荧光引导手术结果报告最低要求,未报告系统检索方法或证据分级。
诊断标准与关键数值
- 临床试验应呈现三项关键内容:术中成像、标本定位与病理对照、靶点验证。
- 定性分析包括明场图像、黑白荧光图像、伪彩荧光叠加图像和/或热图,以色彩谱显示荧光信号强度差异。
- 定量分析包括术中数据(图像或视频、原始数值及比值)、标本定位(使用新鲜组织将荧光与疾病存在进行对照)及靶点验证(确定特定区域荧光强度相对于受体密度的关系)。
临床应用与阅片要点
- 建议按术中成像、标本定位与病理对照、靶点验证三项关键内容组织荧光引导手术的试验报告。
- 定性报告应包含明场图像、黑白荧光图像、伪彩荧光叠加图像和/或热图。
- 定量报告应包含术中图像或视频、原始数值及比值,并使用新鲜组织进行标本定位以对照荧光与疾病存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Intraoperative fluorescence imaging is particularly well-suited for surgical applications due to its inherently high sensitivity, resolution, and ability to provide images in real-time. To date, the intraoperative observation of fluorescence has largely been subjective. With the need to show objective evidence in order to demonstrate the benefit of this technique, quantitative data needs to be provided to overseeing regulatory bodies. Standardization of fluorescence imaging protocols would improve reproducibility and minimize inter- and intra-institution variance. This would allow studies to be conducted using the same injection techniques, imaging times, reconstruction methods, and analyses. Here, we provide recommendations for standardized methodologies with the goal of setting a minimum requirement for reporting fluorescence-guided surgery results based on both qualitative and (semi-) quantitative data collection. Clinical trials using fluorescence-guided surgery should present results of three critical elements; 1) intra-operative imaging, 2) specimen mapping and pathology correlation, and 3) target validation. Qualitative analyses should consist of a bright field image, black-and-white fluorescence image, pseudo-colored fluorescence overlay image, and/or heat-map whereby fluorescence signal intensity differences are displayed on a color spectrum. Quantitative analyses should include 1) intraoperative data (consisting of images or video, raw numeric values and ratios); 2) specimen mapping, for correlation of fluorescence with the presence of disease (performed using fresh tissue); and 3) target validation (designed to determine fluorescence intensity relative to receptor density of a specific area). Including the aforementioned methods of both qualitative and quantitative analyses will ensure that trial results are comparable and could be collated in future studies to expedite FDA approval.
引用
- Tummers WS, Warram JM, van den Berg NS, et al. Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics. 2018. PMID: 30555550. doi:10.7150/thno.27384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。